Trials stopped early for benefit? Not so fast!: Commentary

Critical Care

Volumn 11, Issue , 2007, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DROTRECOGIN; PLACEBO; RECOMBINANT TISSUE FACTOR PATHWAY INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANCER; CARDIOLOGY; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DATA ANALYSIS; DATA EXTRACTION; DECISION MAKING; DRUG INDUSTRY; DRUG RESEARCH; EMBASE; FOLLOW UP; FUNDING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL INFORMATION; MEDLINE; PATIENT SAFETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; SAMPLE SIZE; SHORT SURVEY; SYSTEMATIC REVIEW;

EID: 42749107466     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc5676     Document Type: Short Survey

References (13)

1. Montori VM Devereaux PJ Adhikari NK Burns KE Eggert CH Briel M Lacchetti C Leung TW Darling E Bryant DM Bucher HC Schunemann HJ Meade MO Cook DJ Erwin PJ Sood A Sood R Lo B Thompson CA Zhou Q Mills E Guyatt GH Randomized trials stopped early for benefit: A systematic review JAMA 2005 294 2203-2209 10.1001/jama.294.17.2203 16264162
2. Begg C Cho M Eastwood S Horton R Moher D Olkin I Pitkin R Rennie D Schulz KF Simel D Stroup DF Improving the quality of reporting of randomized controlled trials. The CONSORT statement JAMA 1996 276 637-639 10.1001/jama.276.8.637 8773637
3. Moher D Schulz KF Altman D The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials JAMA 2001 285 1987-1991 10.1001/jama.285.15.1987 11308435
4. Ioannidis JP Contradicted and initially stronger effects in highly cited clinical research JAMA 2005 294 218-228 10.1001/jama.294.2.218 16014596
5. Abraham E Reinhart K Opal S Demeyer I Doig C Rodriguez AL Beale R Svoboda P Laterre PF Simon S Light B Spapen H Stone J Seibert A Peckelsen C De Deyne C Postier R Pettila V Artigas A Percell SR Shu V Zwingelstein C Tobias J Poole L Stolzenbach JC Creasey AA Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: A randomized controlled trial JAMA 2003 290 238-247 10.1001/jama.290.2.238 12851279
6. Angus DC Crowther MA Unraveling severe sepsis: Why did OPTIMIST fail and what's next? JAMA 2003 290 256-258 10.1001/jama.290.2.256 12851282
7. Pocock S White I Trials stopped early: Too good to be true? Lancet 1999 353 943-944 10.1016/S0140-6736(98)00379-1 10459899
8. Schulz KF Grimes DA Multiplicity in randomised trials II: Subgroup and interim analyses Lancet 2005 365 1657-1661 10.1016/S0140-6736(05)66516-6 15885299
9. Poldermans D Boersma E Bax JJ Thomson IR van de Ven LL Blankensteijn JD Baars HF Yo TI Trocino G Vigna C Roelandt JR van Urk H The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group N Engl J Med 1999 341 1789-1794 10.1056/NEJM199912093412402 10588963
10. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network N Engl J Med 2000 342 1301-1308 10.1056/NEJM200005043421801 10793162
11. Bernard GR Vincent JL Laterre PF LaRosa SP Dhainaut JF Lopez-Rodriguez A Steingrub JS Garber GE Helterbrand JD Ely EW Fisher CJ Jr Efficacy and safety of recombinant human activated protein C for severe sepsis N Engl J Med 2001 344 699-709 10.1056/NEJM200103083441001 11236773
12. Van den Berghe G Wouters P Weekers F Verwaest C Bruyninckx F Schetz M Vlasselaers D Ferdinande P Lauwers P Bouillon R Intensive insulin therapy in the critically ill patients N Engl J Med 2001 345 1359-1367 10.1056/NEJMoa011300 11794168
13. Pocock SJ When (not) to stop a clinical trial for benefit JAMA 2005 294 2228-2230 10.1001/jama.294.17.2228 16264167